DACVCP logo
Focused certification exam prep
Start practice

DACVCP Exam Dates 2026: Testing Windows, Deadlines & Scheduling

TL;DR
  • The published 2026 DACVCP administration: Phase I on May 19 and Phase II on June 30, both remote via ExamSoft.
  • Both 2026 dates have passed, and no 2027 schedule has been verified, so confirm directly with the ACVCP.
  • Phase II applications are ordinarily due October 1 before the exam year; intent to sit is due February 1.
  • Both phases must be passed within a five-year eligibility window starting with the first eligible exam year after Phase I approval.

What the ACVCP Has Actually Published for 2026

Candidates searching for DACVCP exam dates often expect a rolling calendar with many testing windows, as some credentialing programs offer. The Diplomate, American College of Veterinary Clinical Pharmacology (DACVCP) credential works differently. It is administered by the American College of Veterinary Clinical Pharmacology (ACVCP) as a once-a-year, two-phase examination, and the dates are set by the College rather than chosen from a vendor's open scheduling grid.

For the 2026 cycle, the ACVCP's Candidate Information page lists a single administration of each phase: Phase I on May 19 and Phase II on June 30. Both were delivered remotely using ExamSoft. Because those dates have now passed, this article treats them as the documented pattern of the 2026 cycle and as a planning reference, not as upcoming opportunities.

Verification note: A 2027 administration schedule has not been verified. Anything you read elsewhere that presents specific 2027 dates as settled should be checked against the ACVCP's Candidate Information page before you build a study plan around it. For the full eligibility picture that sits behind these dates, see our guide to DACVCP requirements, prerequisites and how to qualify.

The Two-Phase Calendar at a Glance

The DACVCP route is sequential. You cannot sit Phase II until you have passed Phase I and had your credentials approved, so the "exam date" question is really two questions with different gating conditions.

ItemPhase IPhase II
2026 dateMay 19June 30
2026 deliveryRemote, ExamSoftRemote, ExamSoft
Format200 multiple-choice questions in two 100-question sessionsTen question groups (written response, multiple choice, fill-in-the-blank, extended matching) worth 200 points across two 100-point sessions
Ordinary schedule08:00-12:00 and 14:00-18:00 local timeEight active hours ordinarily
Gate to sitLegally qualified to practice veterinary medicine; enrolled in or completed approved ACVCP residency training; two referencesCompleted approved training, Phase I pass, approved credentials, documentation and transcripts, two qualifying papers

Note that Phase II's 200 points are a scoring total, not a count of questions. Do not translate the 200-point figure into 200 items when planning your pacing.

Remote Delivery on ExamSoft: What It Means for Scheduling

The 2026 Candidate Information notice states that both phases were delivered remotely. Some generic phase-page language elsewhere on the ACVCP site still refers to a testing location or on-site practice. For the 2026 delivery arrangement, the dated Candidate Information notice is the controlling source, so plan around remote delivery unless the College announces otherwise for a later year.

Remote delivery shifts scheduling concerns from travel and venue logistics to technical readiness:

  • Your own laptop. Candidates supply a compatible Windows or Mac laptop running Examplify, the ExamSoft exam-taking application, with administrator privileges.
  • Encrypted exam files. Examinations are downloaded in encrypted form and unlocked with a proctor password supplied at exam time.
  • Locked-down mode. Once examination mode starts, internet access, files and other applications are blocked.
  • Rehearsal opportunities. The College makes advance practice examinations available, which serve double duty: they let you test your software setup and they familiarize you with how questions are structured.

Key Takeaway

Treat the practice examination as a technical dry run on the exact laptop you will use on exam day, not just as content review. An administrator-privilege or software-compatibility problem discovered the week of the exam is far more costly than one found a month earlier.

How the Exam Day Is Structured

Phase I is a single exam day split into two sessions of 100 multiple-choice questions each. The ordinary schedule runs 08:00-12:00 and 14:00-18:00 local time, which gives eight active examination hours with a midday break that does not count toward them. That is roughly two and a half minutes per question on average, but clinical pharmacology items vary widely, so expect uneven pacing: a short recall item on an adverse event leaves time for a multi-step pharmacokinetic reasoning item.

Phase II also provides eight active hours under its ordinary schedule, but the item mix is considerably more varied. Its ten question groups draw on written responses, multiple choice, fill-in-the-blank and extended matching. The two 100-point sessions mean you are managing points, not question counts, and a single written-response group may carry substantial weight. Candidates should rehearse switching between response types because the cognitive demand of composing a written answer on, say, experimental design is very different from selecting from an extended matching list.

If you want a realistic read on difficulty before committing to a date, our article on how hard the DACVCP exam is walks through what makes the format demanding.

Application, Credentials and Intent-to-Sit Deadlines

The dates candidates most often miss are not the exam days themselves but the administrative deadlines that precede them. According to the ACVCP's published guidance, applications are ordinarily due October 1 of the year before the examination year, and the intent to sit is due February 1 of the examination year. The currently dated candidate checklist covers October 1, 2025 and February 1, 2026, which corresponds to the 2026 cycle.

  1. October 1 (prior year): Application deadline. For Phase I, this is the application with two references, along with confirmation of legal qualification to practice veterinary medicine and enrollment in or completion of approved ACVCP residency training.
  2. February 1 (exam year): Intent to sit deadline. For Phase II, this is also the date by which your two peer-reviewed papers must be accepted or published.
  3. Phase I exam day (2026: May 19): Sit Phase I if you are in the Phase I stage of your pathway.
  4. Phase II exam day (2026: June 30): Sit Phase II if your credentials have been approved and you have passed Phase I.

Because the application deadline falls roughly seven to eight months before the exam, your effective "registration window" closes long before most people start intensive studying. Anyone aiming for a particular exam year should be working backward from the preceding October 1.

The February 1 Paper Deadline and Why It Drives Everything

Phase II is where scheduling gets genuinely complicated, because eligibility depends on publication outcomes you do not fully control. The Phase II credentials review requires two peer-reviewed papers accepted or published by February 1 of the examination year. The specifics matter:

  • At least one paper must be original veterinary clinical pharmacology research.
  • The other may be original research or an eligible evidence-based systematic review or meta-analysis.
  • First authorship is required on at least one of the two.
  • Neither paper may have been used to satisfy requirements for another specialty board.
  • Publication must not predate the beginning of training by more than two years.
Why this matters for dates: A manuscript sitting in peer review on February 1 does not count. Journal turnaround is unpredictable, so candidates who want to sit Phase II in a given year should treat the paper deadline as a hard stop that effectively moves their submission deadline many months earlier. A single delayed acceptance can push your Phase II attempt back an entire year.

Phase II candidates also submit credentials, course documentation and transcripts, and pay a credentials review fee. Our DACVCP certification cost breakdown covers the money side of this in detail.

The Five-Year Eligibility Window

One scheduling rule is easy to overlook: you must pass both phases within a five-year eligibility period. The period begins with the first eligible examination year after Phase I approval. The ACVCP's own example illustrates it: if your Phase I application is approved in December 2025, the 2026 through 2030 examinations fall within your window.

This is an examination eligibility window, not a credential renewal cycle. It governs how long you have to complete the exam sequence, not how long a granted credential remains valid. The distinction matters because candidates sometimes conflate the two.

Practically, five years allows several attempts at each phase, but it is not unlimited. Retakes require paying the respective examination fee again, and every year lost to a missed deadline or an unaccepted paper consumes part of the window. Build your timeline so that a single setback does not leave you facing the end of your eligibility period with a phase still unpassed.

Fees and When You Pay Them

The ACVCP's Candidate Deadlines and Fees page lists the following for the published 2026 cycle:

FeeAmount (USD)
Phase I application$75
Phase I examination$200
Phase II credentials review$250
Phase II examination$300

Two cautions on interpretation. First, the "Becoming a Resident" page separately describes a $75 first-year candidate registration fee. The public pages do not establish whether that charge is the same as the Phase I application fee or an additional one, so confirm with the ACVCP before budgeting rather than assuming either way. Second, refund language is inconsistent: the general fee page allows refunds only for extenuating circumstances accepted by the Board, while the individual phase pages describe examination fees as nonrefundable. Plan as though exam fees will not come back to you.

For a fuller picture of what residency, travel-free remote testing and retakes mean for total spend, see the complete pricing breakdown and our analysis of whether the DACVCP is worth it.

Mapping Content to the Calendar

Knowing the dates is only useful if you know what you must be ready to demonstrate on them. The retained preparation headings come from two sources, and it is important to keep them distinct. Domains 1 through 22 are drawn from the ACVCP's Suggested Blueprint for Phase I, last revised December 2021. They are dated preparation-curriculum topics, not a verified current or exhaustive exam outline, because the complete current blueprints could not be retrieved. Domains 23 through 26 are the four examination subject categories listed on the current Phase II examination page, though current category percentages are not published there.

Phase I preparation headings (Domains 1-9): the foundation

These headings cover the principles on which everything else rests.

  • Physiochemical characteristics of active pharmaceutical ingredients (the source spelling)
  • Pharmacodynamics, drug movement and pharmacokinetics
  • Factors impacting drug movement and/or drug response
  • Routes of administration and dosing forms, including relevant delivery devices
  • Adverse events and causes for therapeutic failure

Phase I preparation headings (Domains 10-22): the organ-system and drug-class breadth

This is where the volume of material accumulates.

  • Nervous System, Renal, Cardiovascular, Gastrointestinal, Reproduction, Endocrine, and General and special senses
  • Control of inflammation/immunomodulation and Anticancer drugs
  • Fluid therapy and Anti-infectives
  • Botanical/Herbals and Disinfectants/antiseptics

Phase II examination categories (Domains 23-26): application and judgment

These are the four subject categories on the current Phase II page.

  • Therapeutics
  • Pharmacokinetics and Therapeutic Drug Monitoring
  • Experimental Design, Statistics and Analytical Methods
  • Regulatory Pharmacology

For a deeper treatment of how each area is approached, see our guide to all 26 DACVCP content areas. Note that the "26" counts the supplied headings and is not an official combined exam-domain count.

A Backward-Planning Timeline Tied to DACVCP Content

Generic study calendars ignore the fact that this credential has fixed deadlines and a content split between foundational and applied material. A better approach is to anchor your schedule to the gating dates and assign domains by their role. The sketch below assumes a Phase I attempt in a May administration; adjust the spacing to your own residency calendar.

Months 1-2

Foundations first (Domains 1-9)

  • Work through pharmacodynamics, drug movement and pharmacokinetics before anything organ-specific, since later domains assume them.
  • Practice the quantitative reasoning that supports pharmacokinetic questions.
Months 3-4

Organ systems and drug classes (Domains 10-22)

  • Group nervous, cardiovascular, renal and endocrine content together to see cross-system drug interactions.
  • Give anti-infectives and anticancer drugs dedicated blocks because of their breadth.
Final weeks

Rehearsal and technical readiness

  • Take the advance practice examination on your exam laptop, with Examplify installed and administrator rights confirmed.
  • Reserve time for the weaker domains your practice results expose.

For Phase II, shift emphasis toward the four applied categories. Experimental Design, Statistics and Analytical Methods and Regulatory Pharmacology reward a different kind of preparation than recall-heavy Phase I material. Written-response and extended-matching formats also reward practice producing structured answers under time pressure. Our DACVCP study guide expands on resources and sequencing, and the one-page cheat sheet is useful for last-week consolidation.

Practice with the format: The questions you meet in the exam room reward clinical reasoning, not just memorization. Working through realistic items in our DACVCP practice tests helps you identify which of the 22 preparation headings still need attention before your exam date.

Planning for 2027 When No Schedule Is Posted

Because the 2026 dates are behind us and no 2027 schedule has been verified, the responsible approach is to plan from the pattern, not the specifics. The 2026 cycle followed this rhythm: application due the prior October 1, intent to sit due February 1, Phase I in mid-spring, Phase II in early summer. A reasonable working assumption is that a later cycle will follow a similar structure, but treat that as a planning assumption, not a promise.

  • Check the Candidate Information page on the ACVCP site for the current administration notice.
  • Contact the ACVCP directly if the posted checklist still references 2025-2026 dates.
  • Do not rely on legacy PDFs. Older blueprint and bylaw files may be outdated, and some direct requests to legacy documents return errors.
  • Keep your residency and publication timeline flexible so that a shift of a few weeks in either exam date does not derail your submission plans.

Delivery format is another variable. The remote ExamSoft arrangement applied to the 2026 administration, but a future year's notice is what will govern that year. Confirm the mode of delivery when the next schedule is posted.

If you are weighing whether to start this pathway at all, the DACVCP salary guide and our overview of DACVCP jobs cover where Diplomates tend to work, while the pass rate article and the passing score guide explain what is and is not publicly known about outcomes. For context, passing points are recommended by the Examination Committee and ad hoc reviewers for Board approval, and a fixed numerical pass mark and current pass rate have not been verified.

Frequently Asked Questions

When is the DACVCP exam in 2026?

The ACVCP's Candidate Information page published Phase I for May 19 and Phase II for June 30, both delivered remotely using ExamSoft. Both dates have passed. A 2027 schedule has not been verified, so check the ACVCP directly.

Can I choose my own testing date or location?

Based on the published 2026 arrangement, no. The ACVCP administers each phase once on a set date, and the 2026 administration was remote rather than at a testing location, so candidates sat from their own location using their own compatible laptop.

What are the key deadlines before the exam?

Applications are ordinarily due October 1 of the year before the exam, and intent to sit is due February 1 of the exam year. For Phase II, your two qualifying peer-reviewed papers must also be accepted or published by February 1.

How long do I have to pass both phases?

You must pass both phases within a five-year eligibility period beginning with the first eligible examination year after Phase I approval. For example, approval in December 2025 permits examinations from 2026 through 2030. This is an exam window, not credential renewal.

Are exam fees refundable if I miss my date?

Treat them as nonrefundable. The phase pages describe examination fees as nonrefundable, although the general fee page permits refunds only for extenuating circumstances accepted by the Board. Retakes require paying the respective examination fee again.

For related background on the credential itself, see what DACVCP is, the broader DACVCP certification overview, and the dedicated page on DACVCP exam dates.

Ready to pass your DACVCP exam?

Put this into practice with free DACVCP questions across every exam domain.